EMA Homes In On How To Improve RWD Quality

Draft guidance from the European Medicines Agency explores how data quality can impact the use of real-world data to generate real-world evidence for regulatory assessments.

Female engineer concept. GUI (Graphical User Interface).
New draft guidance explains how to assess and improve the quality of real-world data (Shutterstock)

The European Medicines Agency is seeking feedback on draft guidance that aims to provide “actionable and focused recommendations” for assessing and improving the quality of real-world data (RWD) for regulatory use.

More from Real-World Evidence

More from Pink Sheet